Home

Silence Therapeutics Plc - American Depository Share (SLN)

5.5000
+0.00 (0.00%)
NASDAQ · Last Trade: Jun 5th, 5:49 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
12 Health Care Stocks Moving In Tuesday's After-Market Sessionbenzinga.com
Via Benzinga · June 3, 2025
12 Health Care Stocks Moving In Tuesday's Pre-Market Sessionbenzinga.com
Via Benzinga · May 13, 2025
These stocks are moving in today's pre-market sessionchartmill.com
Discover the top movers in Tuesday's pre-market session and stay informed about market dynamics.
Via Chartmill · April 1, 2025
Deep Dive Into Silence Therapeutics Stock: Analyst Perspectives (7 Ratings)benzinga.com
Via Benzinga · March 4, 2025
Earnings Scheduled For February 27, 2025benzinga.com
Via Benzinga · February 27, 2025
Deep Dive Into Silence Therapeutics Stock: Analyst Perspectives (7 Ratings)benzinga.com
Via Benzinga · February 3, 2025
The Analyst Landscape: 6 Takes On Silence Therapeuticsbenzinga.com
Via Benzinga · December 10, 2024
Analyst Scoreboard: 4 Ratings For Silence Therapeuticsbenzinga.com
Via Benzinga · November 15, 2024
Wall Street's Top 10 Stock Calls This Week - Saturday, Feb. 15talkmarkets.com
What has Wall Street been buzzing about this week? Here is a look at the top 5 buy calls and the top 5 sell calls made by Wall Street's best analysts during the trading week of Feb. 10-14, 2025.
Via Talk Markets · February 15, 2025
This IBM Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesdaybenzinga.com
Via Benzinga · February 11, 2025
Top 3 Health Care Stocks That May Explode In Q4benzinga.com
Via Benzinga · December 18, 2024
Silence Therapeutics' Zerlasiran Has Competitive Concerns: Analystbenzinga.com
Silence Therapeutics' Phase 2 data shows zerlasiran achieves over 80% Lp(a) reduction in ASCVD patients but faces dosing frequency challenges.
Via Benzinga · November 19, 2024
Top 3 Health Care Stocks You'll Regret Missing In Q4benzinga.com
Via Benzinga · November 19, 2024
Analyst Expectations For Silence Therapeutics's Futurebenzinga.com
Via Benzinga · August 16, 2024
The Analyst Landscape: 6 Takes On Silence Therapeuticsbenzinga.com
Via Benzinga · June 20, 2024
What 7 Analyst Ratings Have To Say About Silence Therapeuticsbenzinga.com
Via Benzinga · May 17, 2024
Beyond The Numbers: 7 Analysts Discuss Silence Therapeutics Stockbenzinga.com
Via Benzinga · April 22, 2024
SLN Stock Earnings: Silence Therapeutics Reported Results for Q2 2024investorplace.com
Silence Therapeutics just reported results for the second quarter of 2024.
Via InvestorPlace · August 15, 2024
The 3 Best Gene Editing Stocks to Buy in August 2024investorplace.com
These are the best gene-editing stocks to buy as the biotechs pursue precision therapies to cure rare diseases.
Via InvestorPlace · August 7, 2024
Morgan Stanley Predicts Triple-Digit Rally for These 3 Stocksinvestorplace.com
It takes a special set of circumstances for high-growth stocks to double in value in one year but analyst says these three can do it.
Via InvestorPlace · July 25, 2024
SLN Stock Earnings: Silence Therapeutics Reported Results for Q1 2024investorplace.com
Silence Therapeutics just reported results for the first quarter of 2024.
Via InvestorPlace · May 16, 2024
3 Biotech Stocks to Turn $5,000 Into $1 Million: April 2024investorplace.com
Biotech stocks can offer some of the most explosive, exciting opportunities on the market.That is, if you find the right one.
Via InvestorPlace · April 11, 2024
7 Biotech Stocks Ready to Ride the Sector’s Resurgenceinvestorplace.com
With investors seeking new opportunities with certain segments appearing stretched, biotech stocks offer a viable canvas.
Via InvestorPlace · March 18, 2024
What 4 Analyst Ratings Have To Say About Silence Therapeuticsbenzinga.com
Via Benzinga · March 13, 2024
These Analysts Boost Their Forecasts On Silence Therapeutics After Full Year 2023 Resultsbenzinga.com
Silence Therapeutics Plc (NASDAQ: SLN) reported a loss for 2023 on Wednesday.
Via Benzinga · March 14, 2024